Pulmonary Hypertension: Revisiting the Historical Facts

Author:

Samir Lakhani Shan,Sunesara Shaleen,Ezhilarasan Santhi Sharanya,Sharma Munish,R. Surani Salim

Abstract

Pulmonary hypertension is a progressive and potentially fatal medical condition. Around 1% of global population is estimated to be affected by it. With significant advancement in diagnostic and therapeutic modalities in pulmonary hypertension, there has been a surge in interest in medical fraternity. We aim to revisit some of the major historical events pertinent to the evolution of the field of pulmonary hypertension. We try to understand how our predecessors in medicine laid foundation based on which the field of pulmonary hypertension is growing.

Publisher

IntechOpen

Reference28 articles.

1. Pulmonary Hypertension Association (PHA). Available from: [Accessed: November 20, 2023]

2. NIH. National Heart, Lung and Blood Institute. Pulmonary Hypertension. Available from: [Accessed: November 20, 2023]

3. Mandras SA, Mehta HS, Vaidya A. Pulmonary hypertension: A brief guide for clinicians. Mayo Clinic Proceedings. 2020;(9):1978-1988. DOI: 10.1016/j.mayocp.2020.04.039

4. Romberg E. Ueber Sklerose der Lungen arterie. Deutsches Archiv für klinische Medizin. 1891;:197-206

5. Van Wolferen SA, Grünberg K, Vonk NA. Diagnosis and management of pulmonary hypertension over the past 100 years. Respiratory Medicine. 2007;(3):389-398

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3